Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» anti-PD-L1
anti-PD-L1
AstraZeneca wins FDA breakthrough status for key cancer drug
Yahoo/Reuters
Wed, 02/17/16 - 10:32 am
AstraZeneca
FDA
breakthrough status
durvalumab
bladder cancer
anti-PD-L1
Pfizer, Merck KGaA launch two more PhIII trials for avelumab
Fierce Biotech
Tue, 12/22/15 - 10:00 pm
Pfizer
Merck KGaA
avelumab
ovarian cancer
anti-PD-L1
Genentech's PD-L1 breakthrough star 'atezo' positioned to vault ahead on cancer
Fierce Biotech
Sun, 05/31/15 - 11:15 am
Genentech
anti-PD-L1
atezolizumab
ASCO
AstraZeneca and Lilly to test new cancer drug combination
Yahoo/Reuters
Fri, 05/29/15 - 10:30 am
Eli Lilly
AstraZeneca
MEDI4736
Cyramza
anti-PD-L1
FDA Grants Breakthrough Therapy Designation To Genetech’s Cancer Immunotherapy
Bidness Etc.
Tue, 02/3/15 - 09:07 am
FDA
breakthrough therapies
Genentech
anti-PD-L1
MPDL3280A
non-small cell lung cancer
Merck KGaA seeks partner for immuno-oncology drug by year-end
Yahoo/Reuters
Thu, 09/18/14 - 08:55 am
Merck KGaA
immuno-oncology
anti-PD-L1
Pharma’s Huge Bet on Immunotherapies
Motley Fool
Wed, 06/25/14 - 07:35 am
immunotherapy
anti-PD-1 immunotherapy
anti-PD-L1
MK-3475
Merck
nivolumab
Roche
Bristol-Myers Squibb
AstraZeneca starts late-stage study of key new cancer drug
Yahoo/Reuters
Thu, 05/8/14 - 10:54 am
AstraZeneca
anti-PD-L1
MEDI4736
non-small cell lung cancer
Pages
« first
‹ previous
1
2